FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2154941270> ?p ?o ?g. }

• W2154941270 endingPage "e1001453" @default.
• W2154941270 startingPage "e1001453" @default.
• W2154941270 abstract "Background Colon cancer (CC) pathological staging fails to accurately predict recurrence, and to date, no gene expression signature has proven reliable for prognosis stratification in clinical practice, perhaps because CC is a heterogeneous disease. The aim of this study was to establish a comprehensive molecular classification of CC based on mRNA expression profile analyses. Methods and Findings Fresh-frozen primary tumor samples from a large multicenter cohort of 750 patients with stage I to IV CC who underwent surgery between 1987 and 2007 in seven centers were characterized for common DNA alterations, including BRAF, KRAS, and TP53 mutations, CpG island methylator phenotype, mismatch repair status, and chromosomal instability status, and were screened with whole genome and transcriptome arrays. 566 samples fulfilled RNA quality requirements. Unsupervised consensus hierarchical clustering applied to gene expression data from a discovery subset of 443 CC samples identified six molecular subtypes. These subtypes were associated with distinct clinicopathological characteristics, molecular alterations, specific enrichments of supervised gene expression signatures (stem cell phenotype–like, normal-like, serrated CC phenotype–like), and deregulated signaling pathways. Based on their main biological characteristics, we distinguished a deficient mismatch repair subtype, a KRAS mutant subtype, a cancer stem cell subtype, and three chromosomal instability subtypes, including one associated with down-regulated immune pathways, one with up-regulation of the Wnt pathway, and one displaying a normal-like gene expression profile. The classification was validated in the remaining 123 samples plus an independent set of 1,058 CC samples, including eight public datasets. Furthermore, prognosis was analyzed in the subset of stage II–III CC samples. The subtypes C4 and C6, but not the subtypes C1, C2, C3, and C5, were independently associated with shorter relapse-free survival, even after adjusting for age, sex, stage, and the emerging prognostic classifier Oncotype DX Colon Cancer Assay recurrence score (hazard ratio 1.5, 95% CI 1.1–2.1, p = 0.0097). However, a limitation of this study is that information on tumor grade and number of nodes examined was not available. Conclusions We describe the first, to our knowledge, robust transcriptome-based classification of CC that improves the current disease stratification based on clinicopathological variables and common DNA markers. The biological relevance of these subtypes is illustrated by significant differences in prognosis. This analysis provides possibilities for improving prognostic models and therapeutic strategies. In conclusion, we report a new classification of CC into six molecular subtypes that arise through distinct biological pathways. Please see later in the article for the Editors' Summary" @default.
• W2154941270 created "2016-06-24" @default.
• W2154941270 creator A5000123841 @default.
• W2154941270 creator A5002733423 @default.
• W2154941270 creator A5002879400 @default.
• W2154941270 creator A5006266119 @default.
• W2154941270 creator A5011594677 @default.
• W2154941270 creator A5017933824 @default.
• W2154941270 creator A5024921834 @default.
• W2154941270 creator A5038592146 @default.
• W2154941270 creator A5041492973 @default.
• W2154941270 creator A5042164918 @default.
• W2154941270 creator A5042627121 @default.
• W2154941270 creator A5050714877 @default.
• W2154941270 creator A5057967242 @default.
• W2154941270 creator A5066227680 @default.
• W2154941270 creator A5072224218 @default.
• W2154941270 creator A5074563241 @default.
• W2154941270 creator A5077144398 @default.
• W2154941270 creator A5079610211 @default.
• W2154941270 creator A5081179224 @default.
• W2154941270 creator A5081199992 @default.
• W2154941270 creator A5084448152 @default.
• W2154941270 creator A5086756070 @default.
• W2154941270 creator A5089818289 @default.
• W2154941270 creator A5090050048 @default.
• W2154941270 date "2013-05-21" @default.
• W2154941270 modified "2023-10-18" @default.
• W2154941270 title "Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value" @default.
• W2154941270 cites W1548779692 @default.
• W2154941270 cites W1995773697 @default.
• W2154941270 cites W2033126020 @default.
• W2154941270 cites W2037475505 @default.
• W2154941270 cites W2041413731 @default.
• W2154941270 cites W2073049760 @default.
• W2154941270 cites W2101136061 @default.
• W2154941270 cites W2103547637 @default.
• W2154941270 cites W2107665951 @default.
• W2154941270 cites W2109972881 @default.
• W2154941270 cites W2114739452 @default.
• W2154941270 cites W2116453600 @default.
• W2154941270 cites W2118017554 @default.
• W2154941270 cites W2120490763 @default.
• W2154941270 cites W2123636561 @default.
• W2154941270 cites W2123927174 @default.
• W2154941270 cites W2124402963 @default.
• W2154941270 cites W2130365699 @default.
• W2154941270 cites W2139230093 @default.
• W2154941270 cites W2141249365 @default.
• W2154941270 cites W2145168501 @default.
• W2154941270 cites W2157840751 @default.
• W2154941270 cites W2157910818 @default.
• W2154941270 cites W2163549507 @default.
• W2154941270 cites W2165389801 @default.
• W2154941270 cites W2169903102 @default.
• W2154941270 cites W2171235660 @default.
• W2154941270 cites W2262414037 @default.
• W2154941270 cites W2315257280 @default.
• W2154941270 cites W4213257593 @default.
• W2154941270 cites W4256632471 @default.
• W2154941270 doi "https://doi.org/10.1371/journal.pmed.1001453" @default.
• W2154941270 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3660251" @default.
• W2154941270 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23700391" @default.
• W2154941270 hasPublicationYear "2013" @default.
• W2154941270 type Work @default.
• W2154941270 sameAs 2154941270 @default.
• W2154941270 citedByCount "1027" @default.
• W2154941270 countsByYear W21549412702012 @default.
• W2154941270 countsByYear W21549412702013 @default.
• W2154941270 countsByYear W21549412702014 @default.
• W2154941270 countsByYear W21549412702015 @default.
• W2154941270 countsByYear W21549412702016 @default.
• W2154941270 countsByYear W21549412702017 @default.
• W2154941270 countsByYear W21549412702018 @default.
• W2154941270 countsByYear W21549412702019 @default.
• W2154941270 countsByYear W21549412702020 @default.
• W2154941270 countsByYear W21549412702021 @default.
• W2154941270 countsByYear W21549412702022 @default.
• W2154941270 countsByYear W21549412702023 @default.
• W2154941270 crossrefType "journal-article" @default.
• W2154941270 hasAuthorship W2154941270A5000123841 @default.
• W2154941270 hasAuthorship W2154941270A5002733423 @default.
• W2154941270 hasAuthorship W2154941270A5002879400 @default.
• W2154941270 hasAuthorship W2154941270A5006266119 @default.
• W2154941270 hasAuthorship W2154941270A5011594677 @default.
• W2154941270 hasAuthorship W2154941270A5017933824 @default.
• W2154941270 hasAuthorship W2154941270A5024921834 @default.
• W2154941270 hasAuthorship W2154941270A5038592146 @default.
• W2154941270 hasAuthorship W2154941270A5041492973 @default.
• W2154941270 hasAuthorship W2154941270A5042164918 @default.
• W2154941270 hasAuthorship W2154941270A5042627121 @default.
• W2154941270 hasAuthorship W2154941270A5050714877 @default.
• W2154941270 hasAuthorship W2154941270A5057967242 @default.
• W2154941270 hasAuthorship W2154941270A5066227680 @default.
• W2154941270 hasAuthorship W2154941270A5072224218 @default.
• W2154941270 hasAuthorship W2154941270A5074563241 @default.
• W2154941270 hasAuthorship W2154941270A5077144398 @default.
• W2154941270 hasAuthorship W2154941270A5079610211 @default.

• next